Skip to main content
Fig. 1 | Biomaterials Research

Fig. 1

From: New opportunities for nanoparticles in cancer immunotherapy

Fig. 1

Cancer–immunity cycle. Tumor antigens released from tumor cells are recognized by antigen-presenting cells (APCs). Matured APCs migrate to the lymph nodes, leading to priming and proliferation of T cells. T cells activated by APCs are transferred to tumor tissues, where they kill tumor cells. Finally, tumor antigens from killed cancer cells induce another round of the immune response, leading to a cancer–immunity cycle

Back to article page